All in all, we propose for the first time that miR-137 can reverse the disease process of osteoarthritis through targeted inhibition of TCF4-mediated AMPK/NF-κB signaling pathway, which may become a new direction for the treatment and prevention of OA. Here, NFKB1 is linked to osteoarthritis.